Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Girón R[au]:

Spanish Guidelines on Treatment of Bronchiectasis in Adults. Martínez-García MÁ et al. Arch Bronconeumol. (2018)

Spanish Guidelines on the Evaluation and Diagnosis of Bronchiectasis in Adults. Martínez-García MÁ et al. Arch Bronconeumol. (2018)

Predicting high risk of exacerbations in bronchiectasis: the E-FACED score. Martinez-Garcia MA et al. Int J Chron Obstruct Pulmon Dis. (2017)

Search results

Items: 1 to 50 of 102

1.

Prevalence and importance of non-tuberculous mycobacteria in adult patients with cystic fibrosis in a hospital in Madrid.

Fernández-Caso B, Vázquez R, Alarcón T, Girón R, López-Giménez MR, Domingo D.

Enferm Infecc Microbiol Clin. 2019 Nov 16. pii: S0213-005X(19)30240-X. doi: 10.1016/j.eimc.2019.09.007. [Epub ahead of print] English, Spanish.

PMID:
31744623
2.

Revealing How Alkali Cations Affect the Surface Reactivity of Stainless Steel in Alkaline Aqueous Environments.

Giron RGP, Chen X, La Plante EC, Gussev MN, Leonard KJ, Sant G.

ACS Omega. 2018 Nov 1;3(11):14680-14688. doi: 10.1021/acsomega.8b02227. eCollection 2018 Nov 30.

3.

Bronchiectasis: When the Published Scientific Evidence Proves Insufficient.

Martinez-Garcia MA, de la Rosa D, Cantón R, Olveira C, Máiz-Carro L, Girón R, Prados C, Blanco M.

Arch Bronconeumol. 2019 Jun;55(6):283-285. doi: 10.1016/j.arbres.2019.05.001. English, Spanish. No abstract available.

4.

Radiographic dose-dependency study of loperamide effects on gastrointestinal motor function in the rat. Temporal relationship with nausea-like behavior.

Vera G, Girón R, Martín-Fontelles MI, Abalo R.

Neurogastroenterol Motil. 2019 Aug;31(8):e13621. doi: 10.1111/nmo.13621. Epub 2019 May 22.

PMID:
31117152
5.

Fluoroscopic Characterization of Colonic Dysmotility Associated to Opioid and Cannabinoid Agonists in Conscious Rats.

Díaz-Ruano S, López-Pérez AE, Girón R, Pérez-García I, Martín-Fontelles MI, Abalo R.

J Neurogastroenterol Motil. 2019 Apr 30;25(2):300-315. doi: 10.5056/jnm18202.

6.

Indazolylketones as new multitarget cannabinoid drugs.

González-Naranjo P, Pérez-Macias N, Pérez C, Roca C, Vaca G, Girón R, Sánchez-Robles E, Martín-Fontelles MI, de Ceballos ML, Martin-Requero A, Campillo NE, Páez JA.

Eur J Med Chem. 2019 Mar 15;166:90-107. doi: 10.1016/j.ejmech.2019.01.030. Epub 2019 Jan 17.

PMID:
30685536
7.

Glycosaminoglycans are differentially involved in bacterial binding to healthy and cystic fibrosis lung cells.

Martin C, Lozano-Iturbe V, Girón RM, Vazquez-Espinosa E, Rodriguez D, Merayo-Lloves J, Vazquez F, Quirós LM, García B.

J Cyst Fibros. 2019 May;18(3):e19-e25. doi: 10.1016/j.jcf.2018.10.017. Epub 2018 Nov 8.

PMID:
30415947
8.

May a sigma-1 antagonist improve neuropathic signs induced by cisplatin and vincristine in rats?

Paniagua N, Goicoechea C, Abalo R, López-Miranda V, Vela JM, Merlos M, Martín Fontelles MI, Girón R.

Eur J Pain. 2019 Mar;23(3):603-620. doi: 10.1002/ejp.1333. Epub 2018 Dec 10.

PMID:
30376213
9.

Prognostic Value of Frequent Exacerbations in Bronchiectasis: The Relationship With Disease Severity.

Martinez-Garcia MÁ, Athanazio R, Gramblicka G, Corso M, Cavalcanti Lundgren F, Fernandes de Figueiredo M, Arancibia F, Rached S, Girón R, Máiz Carro L, de la Rosa Carrillo D, Prados C, Olveira C.

Arch Bronconeumol. 2019 Feb;55(2):81-87. doi: 10.1016/j.arbres.2018.07.002. Epub 2018 Aug 16. English, Spanish.

10.

Addition of hyaluronic acid improves tolerance to 7% hypertonic saline solution in bronchiectasis patients.

Máiz L, Girón RM, Prats E, Clemente MG, Polverino E, Caño S, Cordovilla R, Dorca J, Peñalver C, Baranda F, Martínez-García MA.

Ther Adv Respir Dis. 2018 Jan-Dec;12:1753466618787385. doi: 10.1177/1753466618787385.

11.

Preclinical evaluation of the effects on the gastrointestinal tract of the antineoplastic drug vincristine repeatedly administered to rats.

López-Gómez L, Díaz-Ruano S, Girón R, López-Pérez AE, Vera G, Herradón Pliego E, López-Miranda V, Nurgali K, Martín-Fontelles MI, Uranga JA, Abalo R.

Neurogastroenterol Motil. 2018 Nov;30(11):e13399. doi: 10.1111/nmo.13399. Epub 2018 Jul 4.

PMID:
29971865
12.

Pneumonic and non-pneumonic exacerbations in bronchiectasis: Clinical and microbiological differences.

Polverino E, Rosales-Mayor E, Benegas M, Menendez R, Alcaraz-Serrano V, Ansotegui E, Montull B, Girón RM, Cisneros C, Vendrell M, Muñoz G, Marcos MA, Sanchez M, Torres A.

J Infect. 2018 Aug;77(2):99-106. doi: 10.1016/j.jinf.2018.04.006. Epub 2018 May 7.

PMID:
29746946
13.

Reversible Stereodivergent Cycloaddition of Racemic Helicenes to [60]Fullerene: A Chiral Resolution Strategy.

Girón RM, Ouyang J, Favereau L, Vanthuyne N, Crassous J, Filippone S, Martín N.

Org Lett. 2018 Apr 6;20(7):1764-1767. doi: 10.1021/acs.orglett.8b00256. Epub 2018 Mar 9.

PMID:
29522351
14.

On the regioselectivity of the Diels-Alder cycloaddition to C60 in high spin states.

El Bakouri O, Garcia-Borràs M, Girón RM, Filippone S, Martín N, Solà M.

Phys Chem Chem Phys. 2018 May 3;20(17):11577-11585. doi: 10.1039/c7cp07965f.

15.

Spanish Guidelines on the Evaluation and Diagnosis of Bronchiectasis in Adults.

Martínez-García MÁ, Máiz L, Olveira C, Girón RM, de la Rosa D, Blanco M, Cantón R, Vendrell M, Polverino E, de Gracia J, Prados C.

Arch Bronconeumol. 2018 Feb;54(2):79-87. doi: 10.1016/j.arbres.2017.07.015. Epub 2017 Nov 9. English, Spanish.

16.

Spanish Guidelines on Treatment of Bronchiectasis in Adults.

Martínez-García MÁ, Máiz L, Olveira C, Girón RM, de la Rosa D, Blanco M, Cantón R, Vendrell M, Polverino E, de Gracia J, Prados C.

Arch Bronconeumol. 2018 Feb;54(2):88-98. doi: 10.1016/j.arbres.2017.07.016. Epub 2017 Nov 9. English, Spanish.

17.

Antibiotic resistance and population structure of cystic fibrosis Pseudomonas aeruginosa isolates from a Spanish multi-centre study.

López-Causapé C, de Dios-Caballero J, Cobo M, Escribano A, Asensio Ó, Oliver A, Del Campo R, Cantón R, Solé A, Cortell I, Asensio O, García G, Martínez MT, Cols M, Salcedo A, Vázquez C, Baranda F, Girón R, Quintana E, Delgado I, de Miguel MÁ, García M, Oliva C, Prados MC, Barrio MI, Pastor MD, Olveira C, de Gracia J, Álvarez A, Escribano A, Castillo S, Figuerola J, Togores B, Oliver A, López C, de Dios Caballero J, Tato M, Máiz L, Suárez L, Cantón R.

Int J Antimicrob Agents. 2017 Sep;50(3):334-341. doi: 10.1016/j.ijantimicag.2017.03.034. Epub 2017 Jul 20.

PMID:
28735882
18.

Clinical impact of chronic obstructive pulmonary disease on non-cystic fibrosis bronchiectasis. A study on 1,790 patients from the Spanish Bronchiectasis Historical Registry.

De la Rosa D, Martínez-Garcia MA, Giron RM, Vendrell M, Olveira C, Borderias L, Maiz L, Torres A, Martinez-Moragon E, Rajas O, Casas F, Cordovilla R, de Gracia J.

PLoS One. 2017 May 18;12(5):e0177931. doi: 10.1371/journal.pone.0177931. eCollection 2017.

19.

Antibiotic prescription patterns in Spanish cystic fibrosis patients: results from a national multicenter study.

Caballero JD, Girón R, Del Campo R, Prados C, Barrio MI, Salcedo A, Cantón R.

Farm Hosp. 2017 May 1;41(3):391-400. doi: 10.7399/fh.2017.41.3.10746.

20.

Latin America validation of FACED score in patients with bronchiectasis: an analysis of six cohorts.

Athanazio R, Pereira MC, Gramblicka G, Cavalcanti-Lundgren F, de Figueiredo MF, Arancibia F, Rached S, de la Rosa D, Máiz-Carro L, Girón R, Olveira C, Prados C, Martinez-Garcia MA.

BMC Pulm Med. 2017 Apr 26;17(1):73. doi: 10.1186/s12890-017-0417-3.

21.

Sex bias in diagnostic delay in bronchiectasis: An analysis of the Spanish Historical Registry of Bronchiectasis.

Girón RM, de Gracia Roldán J, Olveira C, Vendrell M, Martínez-García MÁ, de la Rosa D, Máiz L, Ancochea J, Vázquez L, Borderías L, Polverino E, Martínez-Moragón E, Rajas O, Soriano JB.

Chron Respir Dis. 2017 Nov;14(4):360-369. doi: 10.1177/1479972317702139. Epub 2017 Apr 10.

22.

Involvement of Cannabinoid Signaling in Vincristine-Induced Gastrointestinal Dysmotility in the Rat.

Vera G, López-Pérez AE, Uranga JA, Girón R, Martín-Fontelles MI, Abalo R.

Front Pharmacol. 2017 Feb 6;8:37. doi: 10.3389/fphar.2017.00037. eCollection 2017.

23.

Predicting high risk of exacerbations in bronchiectasis: the E-FACED score.

Martinez-Garcia MA, Athanazio RA, Girón R, Máiz-Carro L, de la Rosa D, Olveira C, de Gracia J, Vendrell M, Prados-Sánchez C, Gramblicka G, Corso Pereira M, Lundgren FL, Fernandes De Figueiredo M, Arancibia F, Rached SZ.

Int J Chron Obstruct Pulmon Dis. 2017 Jan 18;12:275-284. doi: 10.2147/COPD.S121943. eCollection 2017.

24.

Etiology of Bronchiectasis in a Cohort of 2047 Patients. An Analysis of the Spanish Historical Bronchiectasis Registry.

Olveira C, Padilla A, Martínez-García MÁ, de la Rosa D, Girón RM, Vendrell M, Máiz L, Borderías L, Polverino E, Martínez-Moragón E, Rajas O, Casas F, Cordovilla R, de Gracia J.

Arch Bronconeumol. 2017 Jul;53(7):366-374. doi: 10.1016/j.arbres.2016.12.003. Epub 2017 Jan 21. English, Spanish.

25.

May cannabinoids prevent the development of chemotherapy-induced diarrhea and intestinal mucositis? Experimental study in the rat.

Abalo R, Uranga JA, Pérez-García I, de Andrés R, Girón R, Vera G, López-Pérez AE, Martín-Fontelles MI.

Neurogastroenterol Motil. 2017 Mar;29(3). doi: 10.1111/nmo.12952. Epub 2016 Sep 30.

PMID:
27686064
26.

Cyclobuteno[60]fullerenes as Efficient n-Type Organic Semiconductors.

Reboredo S, Girón RM, Filippone S, Mikie T, Sakurai T, Seki S, Martín N.

Chemistry. 2016 Sep 12;22(38):13627-31. doi: 10.1002/chem.201602813. Epub 2016 Aug 24.

PMID:
27554067
27.

Prevalence and factors associated with nontuberculous mycobacteria in non-cystic fibrosis bronchiectasis: a multicenter observational study.

Máiz L, Girón R, Olveira C, Vendrell M, Nieto R, Martínez-García MA.

BMC Infect Dis. 2016 Aug 22;16(1):437. doi: 10.1186/s12879-016-1774-x.

28.

The Multiple Faces of Non-Cystic Fibrosis Bronchiectasis. A Cluster Analysis Approach.

Martínez-García MÁ, Vendrell M, Girón R, Máiz-Carro L, de la Rosa Carrillo D, de Gracia J, Olveira C.

Ann Am Thorac Soc. 2016 Sep;13(9):1468-75. doi: 10.1513/AnnalsATS.201510-678OC.

PMID:
27348199
29.

Blockade of sigma 1 receptors alleviates sensory signs of diabetic neuropathy in rats.

Paniagua N, Girón R, Goicoechea C, López-Miranda V, Vela JM, Merlos M, Martín Fontelles MI.

Eur J Pain. 2017 Jan;21(1):61-72. doi: 10.1002/ejp.897. Epub 2016 Jun 24.

30.

[Bordetella petrii chronic colonization. First case in Spain].

Blanco A, Girón RM, Sáez-Nieto JA, Alarcón T.

Rev Esp Quimioter. 2016 Jun;29(3):167-9. Epub 2016 Apr 1. Spanish. No abstract available.

31.

Annual direct medical costs of bronchiectasis treatment: Impact of severity, exacerbations, chronic bronchial colonization and chronic obstructive pulmonary disease coexistence.

de la Rosa D, Martínez-Garcia MA, Olveira C, Girón R, Máiz L, Prados C.

Chron Respir Dis. 2016 Nov;13(4):361-371. doi: 10.1177/1479972316643698. Epub 2016 Jul 7.

32.

Depression and anxiety symptoms in Spanish adult patients with cystic fibrosis: associations with health-related quality of life.

Olveira C, Sole A, Girón RM, Quintana-Gallego E, Mondejar P, Baranda F, Alvarez A, Prados C, Rodríguez-González J, Herrero-Labarga I, Quittner A, Olveira G.

Gen Hosp Psychiatry. 2016 May-Jun;40:39-46. doi: 10.1016/j.genhosppsych.2016.02.002. Epub 2016 Feb 24.

PMID:
26971246
33.

Validation of a Spanish version of the Leicester Cough Questionnaire in non-cystic fibrosis bronchiectasis.

Muñoz G, Buxó M, de Gracia J, Olveira C, Martinez-Garcia MA, Giron R, Polverino E, Alvarez A, Birring SS, Vendrell M.

Chron Respir Dis. 2016 May;13(2):128-36. doi: 10.1177/1479972316632005. Epub 2016 Feb 22.

34.

Tobramycin inhalation powder (TOBI Podhaler) for the treatment of lung infection in patients with cystic fibrosis.

Vazquez-Espinosa E, Marcos C, Alonso T, Giron RM, Gomez-Punter RM, Garcia-Castillo E, Zamora E, Cisneros C, Garcia J, Valenzuela C, Ancochea J.

Expert Rev Anti Infect Ther. 2016;14(1):9-17. doi: 10.1586/14787210.2016.1118344. Epub 2015 Dec 4. Review.

PMID:
26559549
35.

X-ray analysis of gastrointestinal motility in conscious mice. Effects of morphine and comparison with rats.

Girón R, Pérez-García I, Abalo R.

Neurogastroenterol Motil. 2016 Jan;28(1):74-84. doi: 10.1111/nmo.12699. Epub 2015 Oct 21.

PMID:
26486654
36.

[Inhaled medication and inhalation devices for lung disease].

Solé A, Girón RM.

Rev Esp Quimioter. 2015 Sep;28 Suppl 1:19-24. Review. Spanish.

37.

Changes in structural lung disease in cystic fibrosis children over 4 years as evaluated by high-resolution computed tomography.

Carpio C, Albi G, Rayón-Aledo JC, Álvarez-Sala R, Girón R, Prados C, Caballero P.

Eur Radiol. 2015 Dec;25(12):3577-85. doi: 10.1007/s00330-015-3782-4. Epub 2015 May 1.

PMID:
25929944
38.

Prevalence and factors associated with isolation of Aspergillus and Candida from sputum in patients with non-cystic fibrosis bronchiectasis.

Máiz L, Vendrell M, Olveira C, Girón R, Nieto R, Martínez-García MÁ.

Respiration. 2015;89(5):396-403. doi: 10.1159/000381289. Epub 2015 Apr 23.

39.

Long-term safety and efficacy of tobramycin in the management of cystic fibrosis.

Vázquez-Espinosa E, Girón RM, Gómez-Punter RM, García-Castillo E, Valenzuela C, Cisneros C, Zamora E, García-Pérez FJ, Ancochea J.

Ther Clin Risk Manag. 2015 Mar 12;11:407-15. doi: 10.2147/TCRM.S75208. eCollection 2015. Review.

40.

Spanish consensus on the prevention and treatment of Pseudomonas aeruginosa bronchial infections in cystic fibrosis patients.

Cantón R, Máiz L, Escribano A, Olveira C, Oliver A, Asensio O, Gartner S, Roma E, Quintana-Gallego E, Salcedo A, Girón R, Barrio MI, Pastor MD, Prados C, Martínez-Martínez MT, Barberán J, Castón JJ, Martínez-Martínez L, Poveda JL, Vázquez C, de Gracia J, Solé A; en representación del Grupo Español de Consenso del Tratamiento Antimicrobiano en el Paciente con Fibrosis Quística.

Arch Bronconeumol. 2015 Mar;51(3):140-50. doi: 10.1016/j.arbres.2014.09.021. Epub 2015 Jan 20. English, Spanish.

41.

Organocatalysis for new chiral fullerene-based materials.

Girón RM, Reboredo S, Marco-Martínez J, Filippone S, Martín N.

Faraday Discuss. 2014;173:311-22. doi: 10.1039/c4fd00065j.

PMID:
25465649
42.

Economic Impact Linked To the Reduction of Exacerbations When A Treatment Regime With Inhaled Antibiotics Is Switched To Aztreonam Lysine In Patients With Cystic Fibrosis and Chronic Pulmonary Infection Caused By Pseudomonas Aeruginosa.

Sole A, Poveda JL, Giron RM, Prados MC, De GJ, Casado MÁ.

Value Health. 2014 Nov;17(7):A526. doi: 10.1016/j.jval.2014.08.1659. Epub 2014 Oct 26. No abstract available.

43.

Cystic fibrosis in adult age.

Lerín M, Prados C, Martínez MT, Maíz L, Girón R, Solé A, Cabanillas JJ, Alvarez-Sala R.

Rev Clin Esp. 2014 Aug-Sep;214(6):289-95. doi: 10.1016/j.rce.2014.05.001. Epub 2014 Jun 16. English, Spanish.

PMID:
24948579
44.

[Chryseobacterium spp., a new opportunistic pathogen associated with cystic fibrosis?].

Guiu A, Buendía B, Llorca L, Gómez Punter RM, Girón R.

Enferm Infecc Microbiol Clin. 2014 Oct;32(8):497-501. doi: 10.1016/j.eimc.2013.08.003. Epub 2014 Mar 20. Spanish.

PMID:
24656793
45.

Mediterranean diet is associated on symptoms of depression and anxiety in patients with bronchiectasis.

Olveira C, Olveira G, Espildora F, Girón RM, Vendrell M, Dorado A, Martínez-García MÁ.

Gen Hosp Psychiatry. 2014 May-Jun;36(3):277-83. doi: 10.1016/j.genhosppsych.2014.01.010. Epub 2014 Jan 31.

PMID:
24602964
46.

Combining rimonabant and fentanyl in a single entity: preparation and pharmacological results.

Fernández-Fernández C, Callado LF, Girón R, Sánchez E, Erdozain AM, López-Moreno JA, Morales P, Rodríguez de Fonseca F, Fernández-Ruiz J, Goya P, Meana JJ, Martín MI, Jagerovic N.

Drug Des Devel Ther. 2014 Feb 20;8:263-77. doi: 10.2147/DDDT.S55045. eCollection 2014.

47.

Cannabinoid agonists showing BuChE inhibition as potential therapeutic agents for Alzheimer's disease.

González-Naranjo P, Pérez-Macias N, Campillo NE, Pérez C, Arán VJ, Girón R, Sánchez-Robles E, Martín MI, Gómez-Cañas M, García-Arencibia M, Fernández-Ruiz J, Páez JA.

Eur J Med Chem. 2014 Feb 12;73:56-72. doi: 10.1016/j.ejmech.2013.11.026. Epub 2013 Dec 7.

PMID:
24378710
48.

Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score.

Martínez-García MÁ, de Gracia J, Vendrell Relat M, Girón RM, Máiz Carro L, de la Rosa Carrillo D, Olveira C.

Eur Respir J. 2014 May;43(5):1357-67. doi: 10.1183/09031936.00026313. Epub 2013 Nov 14.

49.

Validation of a Quality of Life Questionnaire for Bronchiectasis: psychometric analyses of the Spanish QOL-B-V3.0.

Olveira C, Olveira G, Espildora F, Giron RM, Muñoz G, Quittner AL, Martinez-Garcia MA.

Qual Life Res. 2014 May;23(4):1279-92. doi: 10.1007/s11136-013-0560-0. Epub 2013 Oct 19.

PMID:
24142190
50.

Inhaled antibiotics for the treatment of chronic bronchopulmonary Pseudomonas aeruginosa infection in cystic fibrosis: systematic review of randomised controlled trials.

Máiz L, Girón RM, Olveira C, Quintana E, Lamas A, Pastor D, Cantón R, Mensa J.

Expert Opin Pharmacother. 2013 Jun;14(9):1135-49. doi: 10.1517/14656566.2013.790366. Epub 2013 Apr 16. Review.

PMID:
23586963

Supplemental Content

Support Center